How AI and machine learning are transforming drug discovery
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase,…
AI is revolutionizing drug discovery with its ability to analyze vast datasets. Particularly beneficial in the early drug discovery phase,…
Gene therapy holds transformative potential in treating a wide range of diseases—from cancer and genetic disorders to infectious diseases. While…
As the focus on personalized, equitable healthcare continues to intensify, social determinants of health (SDoH) have attracted significant attention in…
One of the key advantages of blockchain is that it removes the need for patients to provide the same information…
The evolution of pharmaceutical manufacturing is driven largely by the rising demands facing the industry. Inflation, strict regulations and a…
Cell and gene therapies represent a groundbreaking advancement in medical science, offering transformative opportunities for treating complex and previously untreatable…
Introduction Ion chromatography (IC), a highly sensitive technique for separating and quantifying ionic species, was introduced in the 1970s and…
Pharmaceutical supply chains continue to be disrupted by a range of geopolitical factors, including global conflict, economic uncertainty, and especially…
In episode two of The Zelta Podcast, we continue our conversation about AI and supervised machine learning in clinical trials…
The American Society of Clinical Oncology (ASCO) Annual Meeting 2025, held from 30 May to 3 June, in Chicago, Illinois,…